.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Covington
QuintilesIMS
Chubb
Accenture
Boehringer Ingelheim
US Army
Cipla
Harvard Business School
Merck

Generated: June 27, 2017

DrugPatentWatch Database Preview

COSMEGEN Drug Profile

« Back to Dashboard

Which patents cover Cosmegen, and what generic Cosmegen alternatives are available?

Cosmegen is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in COSMEGEN is dactinomycin. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dactinomycin profile page.

Summary for Tradename: COSMEGEN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list37
Patent Applications: see list9,898
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COSMEGEN at DailyMed

Pharmacology for Tradename: COSMEGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
COSMEGEN
dactinomycin
INJECTABLE;INJECTION050682-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
McKesson
Farmers Insurance
US Department of Justice
Teva
Cipla
Chinese Patent Office
Fish and Richardson
Accenture
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot